Search research articles
Contact Us
Filters
Showing results (21-30 of 145) with videos related to
Page
of 15
Sort By:
Heart, Lung & Circulation
|
February 18, 2026
Wild-Type Transthyretin-Related Amyloidosis in Kindreds: A Play of Chance or New Epiphenomenon?
Katherine Kang, Peter Mollee, David Booth, et al.
The Clinical Biochemist. Reviews
|
October 21, 2009
Quantitative serum free light chain assay--analytical issues
Jill Tate, Sheree Bazeley, Stephen Sykes, et al.
Internal Medicine Journal
|
March 6, 2026
TP63-rearranged ALK-negative anaplastic large-cell lymphoma post-transplant lymphoproliferative disorder: the first report of an aggressive entity
Frances Zhao, Jenna Cox, Peter Mollee, et al.
Orbit (Amsterdam, Netherlands)
|
October 4, 2012
Gamma-delta T-cell lymphoma with CNS involvement presenting with proptosis: a case study workup, treatment and prognosis
Kirthi Sugnanam, Lily Ooi, Peter Mollee, et al.
Clinical Biochemistry
|
November 21, 2017
A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteins
Jillian R Tate, David F Keren, Peter Mollee
Annals of Hematology
|
July 8, 2010
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population
Colm Keane, Peter Mollee, Paula Marlton, et al.
The Clinical Biochemist. Reviews
|
March 5, 2019
Report of the Survey Conducted by RCPAQAP on Current Practice for Paraprotein and Serum Free Light Chain Measurement and Reporting: a Need for Harmonisation
Nilika Wijeratne, Jillian R Tate, Louise Wienholt, et al.
The Clinical Biochemist. Reviews
|
October 21, 2009
Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation
Sara L Hall, Jill Tate, Devinder Gill, et al.
British Journal of Haematology
|
March 22, 2003
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype
Kevin W Song, Peter Mollee, Armand Keating, et al.
Leukemia & Lymphoma
|
December 29, 2004
Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?
Joshua Rifkind, Peter Mollee, Hans A Messner, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 145) with videos related to
Sort By:
Page
of 15
Heart, Lung & Circulation
|
February 18, 2026
Wild-Type Transthyretin-Related Amyloidosis in Kindreds: A Play of Chance or New Epiphenomenon?
Katherine Kang, Peter Mollee, David Booth, et al.
The Clinical Biochemist. Reviews
|
October 21, 2009
Quantitative serum free light chain assay--analytical issues
Jill Tate, Sheree Bazeley, Stephen Sykes, et al.
Internal Medicine Journal
|
March 6, 2026
TP63-rearranged ALK-negative anaplastic large-cell lymphoma post-transplant lymphoproliferative disorder: the first report of an aggressive entity
Frances Zhao, Jenna Cox, Peter Mollee, et al.
Orbit (Amsterdam, Netherlands)
|
October 4, 2012
Gamma-delta T-cell lymphoma with CNS involvement presenting with proptosis: a case study workup, treatment and prognosis
Kirthi Sugnanam, Lily Ooi, Peter Mollee, et al.
Clinical Biochemistry
|
November 21, 2017
A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteins
Jillian R Tate, David F Keren, Peter Mollee
Annals of Hematology
|
July 8, 2010
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population
Colm Keane, Peter Mollee, Paula Marlton, et al.
The Clinical Biochemist. Reviews
|
March 5, 2019
Report of the Survey Conducted by RCPAQAP on Current Practice for Paraprotein and Serum Free Light Chain Measurement and Reporting: a Need for Harmonisation
Nilika Wijeratne, Jillian R Tate, Louise Wienholt, et al.
The Clinical Biochemist. Reviews
|
October 21, 2009
Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation
Sara L Hall, Jill Tate, Devinder Gill, et al.
British Journal of Haematology
|
March 22, 2003
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype
Kevin W Song, Peter Mollee, Armand Keating, et al.
Leukemia & Lymphoma
|
December 29, 2004
Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?
Joshua Rifkind, Peter Mollee, Hans A Messner, et al.
Page
of 15